Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Bupropion on Sexual Function of Women with Orgasmic Disorder
IRCT20090801002266N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupropion in female orgasmic disorder (FOD), sponsored by Isfahan University of Medical Sciences. Started Dec 2018; status: completed.
02
Drugs
bupropion
03
Conditions
female orgasmic disorder (FOD)
Beyond the preview
Go deeper on IRCT20090801002266N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090801002266N9.